WHIPPANY, N.J., June 24, 2015 /PRNewswire/ — Pazoo, Inc. (OTC Pinks: PZOO) (German WKN#: A1J3DK), is pleased to report that on Wednesday, June 3, 2015,  Pazoo acquired the remaining 60% of MA & Associates, LLC in exchange for 900,000 shares of Pazoo’s Series C. Preferred stock. This now makes MA & Associates, LLC a 100% wholly-owned subsidiary of Pazoo.

Pazoo is now comprised of three wholly-owned subsidiaries: MA & Associates, LLC, Harris Lee, LLC, and CannabisKing Distribution, LLC. 100% of the revenue generated by each subsidiary will now be consolidated and recorded on Pazoo’s financial statements moving forward.  Management teams from both MA and Pazoo collaboratively felt this move was in the best interests of all parties involved to maximize the inherent value for the overall company.

MA & Associates CEO, Antonio Del Hierro, commented, “The MA Management team felt that it was the perfect moment to have MA & Associates completely join the Pazoo Family of companies. We all have the same goal to create the greatest amount of fundamental value across the board.  The Grand Opening could not have gone better.  We will settle for nothing less than to be the standard for Marijuana testing.”

ABOUT PAZOO Inc.

Pazoo, Inc., is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly-owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry-leading laboratory testing of cannabis. Harris Lee’s and MA’s license agreements with Steep Hill Labs, Inc. allows the Pazoo subsidiaries to use Steep Hill’s top-rated testing protocols in select markets as we expand throughout the USA. Pazoo’s subsidiaries are currently licensed to test cannabis in Nevada, Oregon and Colorado, with other states to come. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website www.pazoo.com.

ABOUT STEEP HILL LABS Inc.

Founded in California in 2008, Steep Hill is a science and technology firm that has become the industry leader in cannabis testing and analytics. With owned and licensed labs in four U.S. states and plans to add labs in New Mexico, Oregon and possibly Jamaica in 2015, Steep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in California – the first state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann™, QuantaCann2™ and GenKit™. Steep Hill provides expert consulting services to many states, countries and municipalities, and the company is developing proprietary genetic testing, mapping and trademark protection services for the industry as well.

Safe Harbor Statement:

This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statement. 

SOURCE Pazoo, Inc.